Ameriprise’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Ameriprise’s Portfolio ELAT Stock Details ELAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,173	Closed	-$200K	–	4081
2022 Q4	$200K	Hold	10,173	–	–	﹤0.01%	3707
2022 Q3	$210K	Hold	10,173	–	–	﹤0.01%	3688
2022 Q2	$330K	Hold	10,173	–	–	﹤0.01%	3540
2022 Q1	$417K	Hold	10,173	–	–	﹤0.01%	3543
2021 Q4	$455K	Hold	10,173	–	–	﹤0.01%	3561
2021 Q3	$508K	Hold	10,173	–	–	﹤0.01%	3403
2021 Q2	$546K	Sell	10,173 -272,800	-96%	-$13.7M	﹤0.01%	3424
2021 Q1	$13M	Buy	282,973 +42,800	+18%	+$2.05M	﹤0.01%	1668
2020 Q4	$11.7M	Buy	240,173 +227,455	+1,788%	+$10.9M	﹤0.01%	1625
2020 Q3	$564K	Hold	12,718	–	–	﹤0.01%	3200
2020 Q2	$494K	Hold	12,718	–	–	﹤0.01%	3203
2020 Q1	$524K	Buy	+12,718	New	+$609K	﹤0.01%	3106

Ameriprise's ELAT Position: Q1 2023 in Review

Ameriprise sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 10,173 shares — an estimated $200K sold.

Ameriprise first reported a position in ELAT in Q1 2020 and held it in 12 quarters. The position peaked at $13M in Q1 2021. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

Ameriprise reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
Ameriprise sold 10,173 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $200K.
Ameriprise first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 12 quarters.
Ameriprise's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $13M in Q1 2021.
0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on Ameriprise's 13F filing for Q1 2023, filed 15 May 2023.